Shearwood McClelland1, Catherine Degnin2, Yiyi Chen2, Jerry J Jaboin3. 1. Department of Radiation Oncology, Indiana University School of Medicine, Indianapolis, United States. 2. Biostatistics Shared Resource, Oregon Health and Science University, Portland, United States. 3. Department of Radiation Medicine, Oregon Health and Science University, Portland, United States.
Abstract
BACKGROUND: The impact of hospital volume on cancer patient survival has been demonstrated in the surgical literature, but sparsely for patients receiving radiation therapy (RT). This analysis addresses the impact of hospital volume on patients receiving RT for the most common central nervous system tumor: brain metastases. MATERIALS AND METHODS: Analysis was conducted using the National Cancer Database (NCDB) from 2010-2015 for patients with metastatic brain disease from lung cancer, breast cancer, and colorectal cancer requiring RT. Hospital volume was stratified as high-volume (≥ 12 brain RT/year), moderate (5-11 RT/year), and low (< 5 RT/year). The effect of hospital volume on overall survival was assessed using a multivariable Cox regression model. RESULTS: A total of 18,841 patients [9479 (50.3%) men, 9362 (49.7%) women; median age 64 years] met the inclusion criteria. 16.7% were treated at high-volume hospitals, 36.5% at moderate-volume, and the remaining 46.8% at low-volume centers. Multivariable analysis revealed that mortality was significantly improved in high-volume centers (HR: 0.95, p = 0.039) compared with low-volume centers after accounting for multiple demographics including age, sex, race, insurance status, income, facility type, Charlson-Deyo score and receipt of palliative care. CONCLUSION: Hospitals performing 12 or more brain RT procedures per year have significantly improved survival in brain metastases patients receiving radiation as compared to lower volume hospitals. This finding, independent of additional demographics, indicates that the increased experience associated with increased volume may improve survival in this patient population.
BACKGROUND: The impact of hospital volume on cancer patient survival has been demonstrated in the surgical literature, but sparsely for patients receiving radiation therapy (RT). This analysis addresses the impact of hospital volume on patients receiving RT for the most common central nervous system tumor: brain metastases. MATERIALS AND METHODS: Analysis was conducted using the National Cancer Database (NCDB) from 2010-2015 for patients with metastatic brain disease from lung cancer, breast cancer, and colorectal cancer requiring RT. Hospital volume was stratified as high-volume (≥ 12 brain RT/year), moderate (5-11 RT/year), and low (< 5 RT/year). The effect of hospital volume on overall survival was assessed using a multivariable Cox regression model. RESULTS: A total of 18,841 patients [9479 (50.3%) men, 9362 (49.7%) women; median age 64 years] met the inclusion criteria. 16.7% were treated at high-volume hospitals, 36.5% at moderate-volume, and the remaining 46.8% at low-volume centers. Multivariable analysis revealed that mortality was significantly improved in high-volume centers (HR: 0.95, p = 0.039) compared with low-volume centers after accounting for multiple demographics including age, sex, race, insurance status, income, facility type, Charlson-Deyo score and receipt of palliative care. CONCLUSION: Hospitals performing 12 or more brain RT procedures per year have significantly improved survival in brain metastases patients receiving radiation as compared to lower volume hospitals. This finding, independent of additional demographics, indicates that the increased experience associated with increased volume may improve survival in this patient population.
Authors: Margreet Lüchtenborg; Sharma P Riaz; Victoria H Coupland; Eric Lim; Erik Jakobsen; Mark Krasnik; Richard Page; Michael J Lind; Michael D Peake; Henrik Møller Journal: J Clin Oncol Date: 2013-07-29 Impact factor: 44.544
Authors: Henry S Park; Elyn H Wang; Charles E Rutter; Christopher D Corso; Veronica L Chiang; James B Yu Journal: J Neurosurg Date: 2015-10-16 Impact factor: 5.115
Authors: Rachel A Greenup; Samilia Obeng-Gyasi; Samantha Thomas; K Houck; Whitney O Lane; Rachel C Blitzblau; Terry Hyslop; E Shelley Hwang Journal: Ann Surg Date: 2018-02 Impact factor: 12.969
Authors: Matthew Koshy; David J Sher; Michael Spiotto; Zain Husain; Herb Engelhard; Konstantin Slavin; Martin K Nicholas; Ralph R Weichselbaum; Chad Rusthoven Journal: J Neurooncol Date: 2017-08-23 Impact factor: 4.130
Authors: Alan Hauser; Sunil W Dutta; Timothy N Showalter; Jason P Sheehan; Surbhi Grover; Daniel M Trifiletti Journal: J Clin Neurosci Date: 2017-11-04 Impact factor: 1.961
Authors: Karl Y Bilimoria; David J Bentrem; Andrew K Stewart; David P Winchester; Clifford Y Ko Journal: J Clin Oncol Date: 2009-07-27 Impact factor: 44.544